City

Guangzhou (1)

Condition

Anlotinib (1)

Early Stage (1)

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type (1)

Open (1)

Peg-aspargase (1)

Phase Two (1)

Radiotherapy (1)

Sintilimab (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Sun Yat-sen University (1)

Collaborator

Intervention

sintilimab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

open

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, Early Stage, Anlotinib Trial in Guangzhou (Sintilimab)

Completed

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
+7 more

Sintilimab

Guangzhou, Guangdong, China

Sun Yat-Sen University Cancer Center

Jun 6, 2022